# Impact of ctDNA in Cancer Early Detection and STAS Evaluation in Patients With GGOs

> **NCT05187767** · — · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 80 (estimated)

## Conditions studied

- Lung Cancer
- Spreading of Tumor
- Circulating Tumor Cell

## Interventions

- **DIAGNOSTIC_TEST:** cf DNA and ct DNA

## Key facts

- **NCT ID:** NCT05187767
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2024-01
- **Final completion:** 2024-10
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05187767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05187767, "Impact of ctDNA in Cancer Early Detection and STAS Evaluation in Patients With GGOs". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05187767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*